Prescription drug · ANDA
Terbinafine Hydrochloride NDC 50090-1048
Terbinafine hydrochloride 250 mg/1 · Tablet · Oral · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-1048-0 | 50090104800 | 30 TABLET in 1 BOTTLE (50090-1048-0)Marketed from Nov 28, 2014 | |
| 50090-1048-1 | 50090104801 | 90 TABLET in 1 BOTTLE (50090-1048-1)Marketed from Nov 28, 2014 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Terbinafine Hydrochloride
- Generic name (nonproprietary)
- terbinafine hydrochloride
- Active ingredients
- Terbinafine hydrochloride — 250 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077714
- Marketing start
- Listing expires
- Other FDA classes
- Allylamine (Chemical structure)
- Identifiers
- Product ID 50090-1048_1d9dab8d-1e3b-4c35-847d-57dbaa8c2eadSPL ID 1d9dab8d-1e3b-4c35-847d-57dbaa8c2eadSPL set ID 6605103b-fd71-4438-8496-f48973b98901RxCUI 313222UNII 012C11ZU6G
- Pharmacologic class
- Allylamine Antifungal
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450090104800followed by a unit qualifier and the quantityPackage 50090-1048-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
1. INDICATIONS AND USAGE Terbinafine tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). Prior to initiating treatment, appropriate nail specimens for laboratory testing [potassium hydroxide (KOH) preparation, fungal culture, or nail biopsy] should be obtained to confirm the diagnosis of onychomycosis. Terbinafine tablets are an allylamine antifungal indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 077714
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Terbinafine Hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | Breckenridge Pharmaceutical, Inc. | 51991-526 |
| Terbinafine Hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | NuCare Pharmaceuticals,Inc. | 68071-4500 |
| Terbinafine Hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 43063-906 |
| Terbinafine Hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 60429-222 |
| Terbinafine Hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | Proficient Rx LP | 71205-127 |
| Terbinafine Hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 43353-893 |
| Terbinafine Hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | Bryant Ranch Prepack | 72162-1595 |
| Terbinafine Hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-364 |
| Terbinafine Hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-0918 |